tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

RHHVF Stock Latest News

Arcus Biosciences drops 6% after Roche lung cancer failure
The FlyArcus Biosciences drops 6% after Roche lung cancer failure
2d ago
GILD
RCUS
Roche failure likely worst case for Arcus study, says Cantor Fitzgerald
PremiumThe Fly
Roche failure likely worst case for Arcus study, says Cantor Fitzgerald
2d ago
GILD
RCUS
Genentech announces FDA approval of Vabysmo 6.0 mg single-dose prefilled syringe
PremiumThe Fly
Genentech announces FDA approval of Vabysmo 6.0 mg single-dose prefilled syringe
2d ago
FDA approves Roche’s Vabysmo prefilled syringe (PFS) for three leading causes of vision loss
PremiumPress Releases
FDA approves Roche’s Vabysmo prefilled syringe (PFS) for three leading causes of vision loss
2d ago
Roche says Phase II/III tiragolumab study failed in lung cancer
PremiumThe Fly
Roche says Phase II/III tiragolumab study failed in lung cancer
3d ago
Roche price target raised to CHF 250 from CHF 240 at Jefferies
PremiumThe FlyRoche price target raised to CHF 250 from CHF 240 at Jefferies
5d ago
Genentech treatment of hemophilia A granted FDA orphan status
PremiumThe Fly
Genentech treatment of hemophilia A granted FDA orphan status
6d ago
Roche’s Vabysmo gets CHMP recommendation for third indication retinal vein occlusion (RVO)
PremiumPress Releases
Roche’s Vabysmo gets CHMP recommendation for third indication retinal vein occlusion (RVO)
9d ago
CHMP recommends EU approval of Roche’s PiaSky for people with PNH, a rare, life-threatening blood condition
PremiumPress Releases
CHMP recommends EU approval of Roche’s PiaSky for people with PNH, a rare, life-threatening blood condition
9d ago
Roche expands access to cervical cancer screening tools with two new WHO prequalification designations, including HPV self-collection
PremiumPress Releases
Roche expands access to cervical cancer screening tools with two new WHO prequalification designations, including HPV self-collection
10d ago
Halozyme: Roche’s OCREVUS SC with ENHANZE receives EC approval
PremiumThe Fly
Halozyme: Roche’s OCREVUS SC with ENHANZE receives EC approval
12d ago
HALO
Roche’s OCREVUS subcutaneous administration approved by European Commission, as first and only twice-a-year injection for relapsing and primary progressive multiple sclerosis
PremiumPress Releases
Roche’s OCREVUS subcutaneous administration approved by European Commission, as first and only twice-a-year injection for relapsing and primary progressive multiple sclerosis
12d ago
Roche launches new analytical units for cobas® pro integrated solutions delivering greater efficiency and capacity to laboratories
PremiumPress ReleasesRoche launches new analytical units for cobas® pro integrated solutions delivering greater efficiency and capacity to laboratories
13d ago
Roche announces launch of new B-cell lymphoma test
PremiumThe Fly
Roche announces launch of new B-cell lymphoma test
17d ago
Roche launches new highly-sensitive test to more easily diagnose patients who may have B-cell lymphoma
PremiumPress Releases
Roche launches new highly-sensitive test to more easily diagnose patients who may have B-cell lymphoma
17d ago
Roche gets FDA clearance on digital pathology solution for diagnostic use
PremiumThe Fly
Roche gets FDA clearance on digital pathology solution for diagnostic use
19d ago
Roche’s Genentech announces results from Phase III STARGLO study
PremiumThe Fly
Roche’s Genentech announces results from Phase III STARGLO study
21d ago
Roche reports Phase 3 STARGLO study met primary endpoint
PremiumThe Fly
Roche reports Phase 3 STARGLO study met primary endpoint
22d ago
Roche’s Phase III STARGLO study demonstrates Columvi significantly extends survival in people with relapsed or refractory diffuse large B-cell lymphoma
PremiumPress Releases
Roche’s Phase III STARGLO study demonstrates Columvi significantly extends survival in people with relapsed or refractory diffuse large B-cell lymphoma
22d ago
Lixte, Roche, NKI collaborate on colon cancer clinical trial
PremiumThe FlyLixte, Roche, NKI collaborate on colon cancer clinical trial
23d ago
LIXT
Roche price target raised to CHF 305 from CHF 295 at Bernstein
PremiumThe Fly
Roche price target raised to CHF 305 from CHF 295 at Bernstein
23d ago
Roche four-in-one molecular test for SARS-CoV-2, Influenza A/B viruses and RSV receives U.S. FDA Emergency Use Authorization
PremiumPress Releases
Roche four-in-one molecular test for SARS-CoV-2, Influenza A/B viruses and RSV receives U.S. FDA Emergency Use Authorization
27d ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >